folic acid has been researched along with Coronary Restenosis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (95.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, Y; Cheng, X; Cui, Y; Fan, F; Huo, Y; Li, Y; Qin, X; Wang, B; Wang, X; Xu, X | 1 |
| Eberli, FR; Flammer, Y; Hess, OM; Meier, B; Pin, R; Roffi, M; Schnyder, G; Turi, ZG | 1 |
| Rouvinez, G; Schnyder, G | 1 |
| Braun, S; Burghartz, M; Kastrati, A; Koch, W; Kölling, K; Lengnick, H; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
| Grégoire, J; L'Allier, PL; Lavoie, MA; Tardif, JC | 1 |
| de Lorgeril, M; Salen, P | 1 |
| Ambrosi, P | 1 |
| Börner, C; Dambrink, JH; De Luca, G; Dille, J; Kallmayer, K; Lange, H; Pasalary, MN; Scherer, E; Suryapranata, H | 1 |
| Herrmann, HC | 1 |
| SoRelle, R | 1 |
| Fowler, B; Herrmann, W; Stanger, O | 1 |
| Halabi, AR; Harrington, RA | 1 |
| Charng, MJ; Chiou, KR; Chung, SL | 1 |
| Motamedi, MR; Namazi, MH; Nazari, N; Saadat, H; Safi, M; Vakili, H | 1 |
| Selzman, CH | 1 |
| Eberli, FR; Flammer, Y; Hess, OM; Lange, H; Meier, B; Pin, R; Roffi, M; Schnyder, G; Turi, ZG | 1 |
| Elmadfa, I; Genser, D; Halbmayer, WM; Hauer, R; Mlczoch, J; Prachar, H | 1 |
| Bostom, AG; Sharaf, B | 1 |
5 review(s) available for folic acid and Coronary Restenosis
| Article | Year |
|---|---|
Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials.
Topics: Coronary Artery Bypass; Coronary Restenosis; Databases, Factual; Dietary Supplements; Folic Acid; Humans; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 6 | 2014 |
Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2003 |
Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; ortho-Aminobenzoates; Oxidative Stress; Probucol; Sirolimus; Vitamins | 2003 |
Homocysteine and post-angioplasty restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Postoperative Complications; Risk Factors | 2003 |
Current approaches to therapy for vascular injury.
Topics: Anti-Bacterial Agents; Arteriosclerosis; Bacterial Infections; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Macrolides | 2001 |
4 trial(s) available for folic acid and Coronary Restenosis
| Article | Year |
|---|---|
Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Stents; Vitamin B 12; Vitamin B 6 | 2003 |
Folate therapy and in-stent restenosis after coronary stenting.
Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Stents; Treatment Failure; Vitamin B 12; Vitamin B 6 | 2004 |
Efficacy of folic acid therapy for prevention of in-stent restenosis: a randomized clinical trial.
Topics: Coronary Angiography; Coronary Restenosis; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Stents | 2006 |
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyridoxine; Vitamin B 12 | 2001 |
11 other study(ies) available for folic acid and Coronary Restenosis
| Article | Year |
|---|---|
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postoperative Complications; Prosthesis Implantation; Stents; Thrombosis; Treatment Outcome; Vitamin B 12 | 2003 |
Dietary prevention of post-angioplasty restenosis. From illusion and disillusion to pragmatism.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex | 2003 |
Prevention of cardiovascular events after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Platelet Aggregation Inhibitors; Risk Factors; Stents; Vitamin B 12; Vitamin B 6 | 2004 |
Clopidogrel resistance marks recurrent risks.
Topics: Aged; Bibliometrics; Cardiology; Clopidogrel; Cohort Studies; Coronary Restenosis; Drug Resistance; Estrogen Receptor alpha; Female; Folic Acid; Genetic Predisposition to Disease; Heart Diseases; Humans; Male; Mass Screening; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recurrence; Risk; Stents; Ticlopidine; Vitamin B 12; Vitamin B 6 | 2004 |
Folate therapy and in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Stents; Vitamin B 6; Vitamin B Complex | 2004 |
Vitamins after angioplasty: maybe not such a good idea after all.
Topics: Angioplasty, Balloon, Coronary; Contraindications; Coronary Restenosis; Folic Acid; Humans; Hyperhomocysteinemia; Stents; Vitamin B 12; Vitamin B 6 | 2004 |
Can vitamin therapy prevent restenosis? Conflicting studies indicate the jury is still out on folate therapy after angioplasty.
Topics: Coronary Restenosis; Drug Combinations; Folic Acid; Homocystine; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
Should we routinely supplement coronary patients with folate therapy to prevent in-stent restenosis?
Topics: Coronary Disease; Coronary Restenosis; Evidence-Based Medicine; Folic Acid; Humans; Male; Middle Aged; Stents | 2005 |
677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Female; Folic Acid; Genotype; Humans; Hyperhomocysteinemia; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Stents; Taiwan; Vitamin B 12 | 2006 |
Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Vitamin B 12 | 2002 |
B vitamins and restenosis after coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Folic Acid; Humans; Hyperhomocysteinemia; Stents; United States; Vitamin B Complex | 2002 |